Study finds J&J’s Covid-19 vaccine effective against viral variants
Data showed antibody and cellular immune responses against SARS-CoV-2 variants of concern as well as the original strain.
Infectious Diseases
Selva’s Covid-19 drug shows activity against SARS-CoV-2 variants
SLV213 was equipotent against existing key variants, including the UK, South African and Brazilian variants.
Pfizer trials lower Covid-19 vaccine dose in children
The Phase II/III trial will enrol up to 4,500 children at more than 90 sites,...
Inovio to start Phase III efficacy trial of Covid-19 vaccine
The trial will be carried out in Latin American and Asian countries to assess the...
RedHill concludes enrolment in Phase II/III Covid-19 drug trial
The trial’s primary endpoint is the proportion of participants not requiring oxygen support by day...
India’s CSIR commences Phase II trials of Niclosamide for Covid-19
The Council of Scientific & Industrial Research (CSIR) in India and Laxai Life Sciences have commenced a Phase II clinical trial of an anti-helminitic drug, Niclosamide, for Covid-19 treatment. The…
Covaxin commences Covid-19 vaccine clinical trials in children
On Tuesday, the All India Institute of Medical Sciences (AIIMS) in Patna started clinical trials of India’s homegrown Covid-19 vaccine Covaxin in children between the ages of two to 18…
Covid-19 vaccine patch outshines injectable jab in pre-clinical study
Vaxxas, an Australian clinical-stage biotechnology firm spun out of the University of Queensland, has announced promising results from pre-clinical trials into its novel high-density microarray patch (HD-MAP) for vaccination against…
NIH initiates clinical trial of mixed Covid-19 vaccine regimens
The National Institutes of Health (NIH) has initiated a Phase I/II clinical trial to evaluate the safety and immunogenicity of mixed Covid-19 vaccine regimens. As part of the trial, adult…
Sputnik V controversy: still no raw data
Sputnik V, the Covid-19 vaccine developed by Moscow’s Gamaleya Research Institute, has suffered a sharp fall from grace since it was first announced. Once a front-runner in the race to…
Aurobindo and Vaxxinity seek DCGI approval for Covid-19 vaccine trial
Aurobindo Pharma and its partner Vaxxinity have sought the Drugs Controller General of India’s (DCGI) approval to carry out Phase II/III clinical trials of its Covid-19 vaccine, UB-612, in the…
